Transcatheter aortic valve implantation (TAVI) has matured into a standard treatment option
for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of …

Registry data that shows a clinically meaningful association of higher mortality and other
major complications with site annual volume below the recommended threshold of 50 …

Objectives The aim of this study was to compare early and late outcomes between redo
surgical aortic valve replacement (AVR) and valve-in-valve (ViV) transcatheter AVR …

Transcatheter aortic valve replacement is now indicated across all risk categories of patients
with symptomatic severe aortic stenosis and has been proposed as first line option for the …

Transcatheter aortic valve implantation (TAVI) within failed bioprosthetic surgical aortic
valves (valve-invalve TAVI) has become an established procedure, currently approved for …

Objectives The aim of this study was to assess the outcomes of severe prosthesis-patient
mismatch (PPM) in the TVT (Transcatheter Valve Therapy) Registry in patients undergoing …

Background Bioprosthetic (BP) valves have been increasingly used for aortic valve
replacement over the last decade. Due to their limited durability, patients presenting with …

Objective Valve-in-valve transcatheter aortic valve replacement (VIV TAVR) can result in
high residual gradients that are associated with increased mortality. Bioprosthetic valve …

In the last 15 years, transcatheter aortic valve implantation (TAVI) technology has met with
rapid uptake, with> 350,000 procedures performed in> 70 countries. Over the same period …

Abstract Nach den 2 Positionspapieren der Deutschen Gesellschaft für Kardiologie (DGK) in
2015 und 2016 zum Thema der kathetergestützten Aortenklappenimplantation (TAVI) haben …